Ruan v. United States and the subjective-knowledge standard for pill-mill prosecutions

The Ruan holding

In Ruan v. United States, 597 U.S. 450 (2022), the Supreme Court resolved a circuit split on the mens rea standard for prescriber prosecutions under 21 U.S.C. §841(a). The Court held unanimously that the “knowingly or intentionally” element of §841 requires the government to prove the defendant knowingly or intentionally acted in an unauthorized manner.

The relevant statutory text:

The Court's reasoning had two pillars. First, “knowingly or intentionally” modifies the entire prohibition, including the “authorized” clause. Second, the implementing regulation at 21 C.F.R. §1306.04 specifies that a prescription is authorized only when it is “issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” Combining these, the Court concluded that the defendant must know — in a subjective sense — that his prescribing was not for legitimate medical purpose or not in the usual course of practice.

The Court rejected the government's argument that an “objectively reasonable physician” standard would suffice. The statute's “knowingly or intentionally” requires subjective awareness, not just objective unreasonableness.

What changed and what didn't

Before Ruan, the law in many circuits had drifted toward an objective standard. Under that standard, a physician could be convicted if a reasonable physician would have recognized the prescribing as departing from legitimate practice. The defendant's subjective belief about legitimacy was either irrelevant or treated as an affirmative defense the defendant had to raise.

After Ruan, the framework has changed in significant ways:

Mens rea is structural

The government bears the burden of proving subjective intent beyond a reasonable doubt. It is not a defense the defendant must raise — it is an element the government must prove.

Good faith is part of the proof

A defendant's good-faith belief in legitimacy is now properly understood as negating the mens rea element. The government must affirmatively disprove good faith as part of its proof, not the defendant prove it as a defense.

Jury instructions changed

Pre-Ruan instructions that allowed an “objectively reasonable physician” conviction are now incorrect. Post-Ruan instructions must require the jury to find the defendant subjectively understood his prescribing was unauthorized.

The pattern of prescribing matters more

To prove subjective intent, the government typically relies on patterns — volume, lack of medical examination, red flags ignored, knowledge of overdoses among patients. The pattern evidence is the bridge from objective conduct to subjective intent.

What didn't change is the underlying offense structure. A pill-mill conviction still requires distribution of a controlled substance outside the authorization framework. Ruan changed the mens rea proof, not the elements of the offense itself.

The subjective-intent inquiry in practice

Federal prosecutors building post-Ruan pill-mill cases focus on evidence of subjective awareness. Common categories of proof:

1. Volume. Extraordinarily high prescribing volumes — particularly of high-strength opioids — create a presumption the defendant knew his prescribing was not legitimate. A practice writing 100 oxycodone prescriptions per day is hard to explain as inadvertent.
2. No or minimal examination. Evidence that the defendant did not examine patients, did not take medical histories, or did not document basic clinical findings supports the inference that the defendant was not prescribing as a legitimate physician.
3. Red flags ignored. Evidence that patients showed obvious signs of dependence, sought specific drugs by name, or had been refused at other practices — and the defendant nevertheless prescribed.
4. Cash-only operations. Many pill-mill cases involve cash-only payment patterns that suggest a deliberate effort to avoid insurance scrutiny. Evidence of cash-pay structure goes to intent.
5. Patient deaths. Evidence that the defendant's patients died of overdose — particularly if the defendant continued similar prescribing after knowing of deaths — is powerful subjective-intent evidence.
6. Communications. Emails, text messages, and recorded conversations in which the defendant acknowledged the irregularity of his prescribing.
7. Undercover buys. Recordings of the defendant prescribing to undercover agents who openly admitted seeking opioids for non-medical purposes.
8. Cooperator testimony. Co-conspirator employees, office staff, or patients who testify about office practice, internal discussions, and the defendant's acknowledged purpose.

The government's burden is to assemble enough of these categories that the jury can find subjective awareness beyond a reasonable doubt. A case built only on prescribing volume without supporting evidence may be insufficient post-Ruan.

Defense strategy after Ruan

Ruan reshaped the defense playbook for pill-mill cases. Several strategic priorities emerge:

Pretrial motion practice

File motions challenging the indictment's mens rea allegations and challenging any jury instructions that don't require subjective intent. The motions should preserve the issue for appeal.

Expert witnesses for defense

Pain-management experts can testify about what reasonable practice looks like in chronic-pain cases, what red flags are clinical artifacts versus diversion signals, and what the defendant's prescribing pattern reflected from a clinical perspective.

Cross-examination of government experts

Government medical experts often testify to objective unreasonableness. Post-Ruan, that testimony alone doesn't prove the offense. Cross-examination should bring out the difference between objectively unreasonable practice and subjective intent to violate the law.

Documentation defense

Where the defendant's records show patient examinations, medical histories, treatment plans, and red-flag responses, those records become evidence of legitimate practice. Even if some patients abused, the defendant's documented approach can support the absence of subjective intent.

Closing argument

Frame the case as one of legitimate-but-imperfect practice versus deliberate deviation. The jury must decide whether the government has proved the defendant knew his prescribing was outside legitimate practice. That is a high bar.

Counsel handling these cases should be prepared for an extended trial. Pill-mill prosecutions typically involve dozens of witnesses, voluminous medical records, and substantial expert testimony. The defense strategy must be organized for that scale.

Implications for non-physician defendants

Ruan addressed physician defendants specifically, but its reasoning extends to non-physician defendants in §841 cases. The same “knowingly or intentionally” analysis applies to:

• Office managers and staff at pill-mill practices.
• Pharmacists who filled the suspect prescriptions.
• Patients who acted as runners or recruiters.
• Distributors and wholesalers in the supply chain.

For each of these categories, the government must prove subjective awareness of the unauthorized nature of the conduct. The proof differs by role — an office manager who knew the practice was operating outside legitimate medical purpose may be liable; an office manager who reasonably believed she was working at a legitimate practice may not.

Pharmacist liability is a particularly active area. After Ruan, the question is whether the pharmacist subjectively knew the prescriptions she was filling were not for legitimate medical purpose. A pharmacist who filled prescriptions without examining red flags may have liability if the red flags were obvious; a pharmacist who applied reasonable verification practices may not.

Sentencing implications

Even when Ruan does not result in acquittal, it affects sentencing in several ways:

Drug quantity and base offense level

The drug-quantity calculation under U.S.S.G. § 2D1.1 still applies. Quantities of pills, converted to morphine-milligram-equivalents or to similar measures, drive the base offense level.

Role enhancements

Enhancements for managerial or organizational roles apply if proven. Cooperating defendants may receive substantial-assistance departures.

Aggravating-factor enhancements

Death-resulting and serious-bodily-injury enhancements under 21 U.S.C. § 841(b)(1)(C) can convert a 0-to-20-year case into a 20-years-to-life case. Counsel should evaluate whether the death-resulting enhancement is provable.

Restitution

MVRA restitution can be substantial in pill-mill cases involving health-insurance fraud (Medicare, Medicaid, private insurers).

Forfeiture

Practice income, real estate, vehicles, and other property derived from the offense are subject to forfeiture under 21 U.S.C. § 853.

The sentencing exposure in a federal pill-mill case is often massive. Even with Ruan's tightened mens rea, defendants who are convicted face potentially decades-long sentences. Trial decisions should be made with full awareness of the sentencing exposure.

Texas state-court implications

Texas state-court prosecutions for prescriber misconduct under the Texas Controlled Substances Act run on parallel tracks. The Texas statute's mens rea language is comparable to the federal statute, although Texas appellate courts have not yet directly adopted Ruan's analysis.

For state-court defendants, post-Ruan arguments include:

• The Texas statute's mens rea language should be construed consistently with the federal counterpart under Ruan.
• Jury instructions should require subjective intent to violate the authorization framework.
• “Good faith” should be treated as part of the State's burden, not an affirmative defense.

The Texas Court of Criminal Appeals has not yet definitively addressed how Ruan affects Texas Health and Safety Code prosecutions. Defense counsel should preserve the argument and develop the record to support adoption of Ruan's framework in state-court proceedings.

Some Texas physician-defendant cases have settled or resolved with reduced charges in light of Ruan's impact on federal cases. The state-court bar has moved more slowly than the federal bar in incorporating the doctrine, but the direction is clear.

Pre-charging engagement and DEA proceedings

Many pill-mill investigations have a long pre-charging phase. The Drug Enforcement Administration audits the practice's prescribing data, interviews former patients and staff, sometimes conducts undercover buys, and works with the U.S. Attorney's Office on charging decisions. The practitioner often knows the investigation is underway months before any criminal complaint is filed.

Pre-charging engagement is one of the most valuable opportunities in this practice area. Several courses of action open up during this window:

Voluntary submission to DEA inquiry

Working with DEA investigators in a controlled manner — with counsel present at all interviews — can sometimes head off criminal charges in favor of administrative discipline. The trade-off is that the practitioner's statements become evidence if criminal charges are later filed.

Practice changes

If the practitioner identifies and addresses problematic prescribing patterns before indictment, the changes themselves can become exculpatory evidence in any subsequent prosecution. They support an inference that the practitioner's prior conduct was clinical error rather than criminal intent.

DEA registration negotiations

The practitioner's DEA registration is separately at risk. The DEA can issue an order to show cause why the registration should not be suspended or revoked, and the registration proceedings run on a different track from the criminal case. Counsel should engage with both proceedings simultaneously.

Pre-indictment plea discussions

In some cases, the U.S. Attorney's Office will discuss disposition before formal charges. A pre-indictment information may be more favorable than the indictment that would otherwise issue, particularly where the practitioner is willing to surrender the DEA registration and provide cooperation.

Practitioners under investigation often resist engaging counsel early because of cost, secrecy concerns, or simple denial. The cost of late engagement is usually substantial. The cases that resolve most favorably are typically those where counsel is brought in during the DEA audit phase, not after the indictment is filed.

For counsel evaluating a prospective Ruan defense, the pre-indictment phase also provides the best opportunity to assemble the medical record and the practice's policies and procedures. Recordkeeping that supports legitimate practice — documentation, treatment plans, urine drug screens, prescription drug monitoring program (PDMP) reviews — is most defensible when it is contemporaneous. Reconstructing the record after indictment is harder.